Latest filing published 19 Jul 2021 for Constellation Pharmaceuticals INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jigar Raythatha, listed as board member, appears in our data through filings on Constellation Pharmaceuticals Inc shares, published by SEC (Form 4). In total, 13 filings cover trades dated from 6 November 2019 to 15 July 2021.
No open-market purchase appears, only 9 sales worth €3.1M. Other entries cover 3 option exercises.
On 19 July 2021 came the latest disclosure, a transaction in Constellation Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration